Imakethe yepompo ye-insulin izofinyelela ku- $ 13.38 billion, Emhlabeni jikelele, ngo-2030 ku-13.6% CAGR

 Imakethe yomhlaba wonke ye ipompo ye-insulin kwaba ilinganiselwa ku-USD 3.9 billion ngo-2020. Kulindeleke ukuthi ifinyelele ku-USD 13.38 billion ngo-2030. Lokhu I-CAGR izoba ngu-13.6% phakathi kuka-2021 no-2030.

Iphampu ye-insulini amadivaysi amancane, alawulwa ngekhompuyutha okulethwa kwezidakamizwa ahlinzeka ngemithamo ye-insulin ezigulini ezinesifo sikashukela. Iphampu ye-insulin yamukelwa kabanzi ngenxa yokusebenza kwayo kahle ekulawuleni nasekulawuleni isifo sikashukela. Baletha imithamo ye-insulin ngokungaguquki nangesikhathi. Isifo sikashukela yisona sizathu esiyinhloko sokukhuphuka kwesidingo sephampu ye-insulin. Ngokwedatha ye-International Diabetes Federation, abantu abayizigidi ezingu-552 emhlabeni wonke okulindeleke ukuba babe nesifo sikashukela ngo-2030. Isifo sikashukela siyimbangela enkulu yokungaboni, isifo sohlangothi, nesifo sezinso. Izibalo zesifo sikashukela ziyanda ngenxa yokushintsha kwendlela yokuphila yabathengi, ukushintshashintsha kwendlela yokudla, kanye nemikhuba yokudla engeyinhle.

Isicelo Sesampula Sekhophi Yemakethe Yephampu Ye-insulin ene-TOC Ephelele kanye Namanani & Amagrafu@ https://market.us/report/insulin-pump-market/request-sample

Imakethe yepompo ye-insulin: Abashayeli

Ukulwisana nokukhula kwemakethe, ukwanda kwesifo sikashukela kubantu abaningi Ukudlondlobala kwesifo sikashukela kungabangelwa izici eziningana, okuhlanganisa ukukhuluphala kanye nempilo yokunganyakazi.

Ngokwe-IDF Diabetes Atlas, abantu abayizigidi ezingama-537 abaneminyaka engama-20-79 bazoba nesifo sikashukela ngo-2021. Isibalo seziguli ezinesifo sikashukela kulindeleke ukuthi senyuke sifinyelele ezigidini ezingama-643 ngo-2030 kanye nezigidi ezingama-783 ngo-2045.

Njengoba sikhula, amathuba okuba nesifo sikashukela ayanda. Ngenxa yalokho, siyanda isibalo sabantu abaneminyaka engaphezu kuka-65 abasengozini yokuba nesifo sikashukela, i-glaucoma, nomfutho wegazi ophakeme.

Ngokusho kwe-Endocrine Society (i-Society for Diabetes Research), ilinganiselwa ku-33.0% yabantu abadala abaneminyaka engama-65 nangaphezulu bazophathwa isifo sikashukela ngo-2022.

Inani elikhulu labanesifo sikashukela sohlobo loku-1 emhlabeni wonke badinga i-insulin ukuze balawule isifo sabo. Ukukhula kweMakethe yePump ye-insulin kulindeleke ukuthi kugqugquzelwe ukwanda kokuqwashisa ngale futha kubantu abanesifo sikashukela kanye nezinzuzo ezihambisana nokulawulwa kwezifo.

Ukugunyazwa Kwakamuva Komkhiqizo kanye nokuba Khona Kwepayipi Eliqinile Ukusheshisa Ukukhula Kwemakethe

Abadlali bemakethe bagxile emizamweni yabo ku-R&D kanye nokwethulwa kwemikhiqizo emisha. Izivivinyo zemitholampilo zisekele i-R&D ngokubonisa ukuthuthuka okuqhubekayo ekulawuleni i-glucose ezigulini ezinesifo sikashukela sohlobo 2 ezithola ukwelashwa kwepompo uma kuqhathaniswa neziguli ezithola imithi yokwelapha ye-Multiple Daily Injection (MDI).

Iphampu ye-insulin Imakethe: Izithiyo

Iphampu ye-insulin enezinga eliphezulu lokutholwa

Lawa maphampu akhulile ngenxa yokwanda kokwanda kwesifo sikashukela sohlobo 1 nohlobo 2 emhlabeni wonke kanye nesidingo esikhulayo sepompo okulula ukulisebenzisa kune-MDI. Ukukhula kwemakethe kulindeleke ukuthi kukhawulwe ngentengo ephezulu yokwelashwa kwepompo ye-insulin. Iphampu, imishini yesimanje yokulethwa kwezidakamizwa eletha izidakamizwa, iguqule ukunakekelwa kwezempilo futhi yamemezela inkathi entsha yemboni yezokunakekelwa kwempilo.

Ngokombhalo kaMdedge, ukwelapha ngepompo kubiza kakhulu kunemijovo eminingi yansuku zonke ye-insulin ezigulini ezinesifo sikashukela. Lo mehluko ufinyelela cishe ku-30%.

Lezi futha zinezindleko ezengeziwe zezinto ezisebenzisekayo ezifana namabhethri, izinzwa, nezinye izinto ezisebenzisekayo. Isilinganiso sentengo yase-US yalezi futha ngu-USD 3,839.6 (intengo ye-OEM). Izindleko zonyaka zezinto ezisetshenziswayo ngu-USD 1,067.0 (intengo ye-OEM). Izintengo nazo zingahluka kuye ngohlobo nosayizi wephampu.

Le futha ayisetshenziswa kakhulu emazweni asafufusa ngenxa yokuntula ulwazi mayelana nezinketho zokwelapha isifo sikashukela kanye nezinqubomgomo ezimbi zokubuyisela imali.

Intengo ephezulu yephampu ye-insulin ikhawulela ukutholwa kwayo emakethe. Lawa maphampu nawo abiza kakhulu kunezindleko zawo futhi kunembuyiselo encane emazweni asathuthuka. Lokhu kuholele ekwehleni kwezinga lokutholwa kwale mikhiqizo ezimakethe zomhlaba.

Noma yimuphi umbuzo?
Buza Lapha Ukuze wenze ngokwezifiso umbiko: https://market.us/report/insulin-pump-market/#inquiry

Iphampu ye-insulin Amathrendi Abalulekile Emakethe:

Isifo sikashukela siyimbangela yokufa ehamba phambili emhlabeni wonke. Kuphinde kube yingozi kwezinye izinkinga zempilo. Ukukhula kwemakethe nakho kuqhutshwa inani elandayo lohlobo 1 lwesifo sikashukela. Imakethe futhi iqhutshwa ukwanda kokuqwashisa ngesifo sikashukela sohlobo loku-1 kanye nezindlela zokuphila zokuziphilisa.

I-IDF Atlas (International Diabetes Foundation) ithi isifo sikashukela sizodala ukufa kwabantu ababalelwa ezigidini eziyisi-6.7 ngo-2021. Ngokwe-IDF Atlas, isibalo seziguli ezinesifo sikashukela kulindeleke ukuthi senyuke ngo-51% ngo-2045.

Ukukhula kwemakethe kuqhutshwa izinhlelo zikahulumeni zokuqwashisa ngezinqubomgomo zokunakekelwa kwezempilo emhlabeni wonke kanye nokulawula isifo sikashukela. Kube nokwenyuka kwezindleko zokunakekelwa kwempilo kanye nesidingo sephampu ye-insulin engenamashubhu engcono. Lawa maphampu e-insulin asebenziseka kalula futhi awabambeki. Lokhu kuzothuthukisa ukukhula kwemakethe esikhathini sokubikezela.

Ukuthuthukiswa kwakamuva:

I-Insulet Corporation imemezele utshalomali oluyisigidi esingu-USD 200 esikhungweni sayo sokukhiqiza saseJohor phakathi neminyaka emihlanu ngoJuni 2, 2022. I-Insulet Corporation ingumholi womhlaba wonke kubuchwepheshe namadivayisi wepompo ye-insulin engenamashubhu. Njengengxenye yenhloso yayo yokukhulisa amandla ayo okukhiqiza emhlabeni wonke, inkampani izokwazi ukukhiqiza i-Omnipod Insulin Management System yayo.

I-Ypsmed neCamDiab bamemezele ukusebenzisana ngo-Ephreli 2022 ukuze bakhe uhlelo oludidiyelwe lwe-AID (ukulethwa kwe-insulin okuzenzakalelayo). Uhlelo oludidiyelwe lwe-AID luzoxhumanisa iFreeStyle Libre3 ka-Abbott ne-Ypsomed's MyLife YpsoPump, okuvumela indlela ehlakaniphile nezenzakalelayo yokuletha i-insulin kusetshenziswa idatha ye-glucose engokoqobo.

Lesi sivumelwano samenyezelwa e-American Diabetes Association Scientific Sessions ngomhlaka-3 Juni 2022 ngu-Diabeloop, umholi womhlaba wonke kwezokwelapha i-AI kanye ne-SOOIL, inkampani ehamba phambili ekwelashweni kwesifo sikashukela. Lokhu kubambisana kuzobavumela ukuthi benze izivivinyo zomtholampilo ukuze bandise ukusebenzisana kwabo futhi banikeze ukufinyelela emikhiqizweni yabo ezigulini eziningi ngemikhiqizo emisha.

Ububanzi boMbiko

izimfanelo	Yekuchumana
Usayizi Wemakethe ngo-2020	I-USD 3.9 billion
Inani lokukhula	I-CAGR ye-13.6%
Iminyaka Yomlando	2016-2020
Unyaka Wesisekelo	2021
Amayunithi amaningi	I-USD In Bn
Inombolo yamakhasi embikweni	Amakhasi angama-200+
Inombolo Yamathebula Nezibalo	150 +
Ifomethi	I-PDF/Excel
Oda Ngqo Lo Mbiko	Iyatholakala- Ukuthenga Lombiko We-Premium Chofoza Lapha

Abadlali Ababalulekile Bemakethe:

• I-Medtronic
• UJohnson noJohnson
• Roche
• SOOIL
• Ukunakekelwa kwe-Tandem Diabetes
• Inkampani Insulet Corp
• I-Valeritas
• I-Microport

Uhlobo

• Ukuhlambalaza
• Idamu
• Ukufakwa Kwesethi

Isicelo

• Thayipha I Isifo Sikashukela
• Thayipha Isifo Sikashukela Sohlobo II

Imboni, Ngesifunda

• I-Asia-Pacific [China, Southeast Asia, India, Japan, Korea, Western Asia]
• IYurophu [Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
• INyakatho Melika [United States, Canada, Mexico]
• Middle East & Africa [GCC, North Africa, South Africa]
• INingizimu Melika [Brazil, Argentina, Columbia, Chile, Peru]

Imibuzo ebalulekile:

• Yibaphi abadlali abakhulu emakethe yephampu ye-insulin?
• Iyini i-CAGR yemakethe yephampu ye-insulin ngo-2019?
• Yiziphi izici eziyinhloko zokushayela emakethe yepompo ye-insulin?
• Iyiphi ingxenye ekhula ngokushesha emakethe yepompo ye-insulin?
• Isiphi isifunda esizobusa imakethe yephampu ye-insulin yomhlaba wonke?
• Liyini inani lesikhathi esizayo lemakethe yephampu ye-insulin?
• Iyiphi ingxenye yemakethe enesabelo esikhulu kunazo zonke sephampu ye-insulin?

Imibiko Ehlobene Eminye Evela Kusayithi lethu le-Market.us:

Imakethe Yamadivayisi Okulethwa Kwe-insulin Okuzenzakalelayo kulindeleke ukuthi ifinyelele esilinganisweni se I-USD 28.87 Izigidigidi ngo-2032 ku-CAGR ye 7.9%, kusukela USD 12.51 billion e 2021.

Imakethe ye-Global Insulin Delivery Systems ilinganiselwa ukuthi izofinyelela inani elingaphezu kuka-USD 11.42 Bn ngo-2017 ku-CAGR engaphezu kuka-7.0% phakathi nesikhathi sokubikezela.

Imakethe yedivayisi ye-Electromagnetic Therapy kulindeleke ukuba I-USD 347.6 Mn ngo-2022 ukuze sifinyelele I-USD 600.0 Mn ngo-2032 a I-CAGR of 6.9%.

imakethe yezinto ezigqokwayo zokulawula ukuzalwa kulindeleke ukuthi ifinyelele esilinganisweni se I-USD 63.36 Bn ngo-2032 a I-CAGR of 13.2%, kusukela I-USD 18.34 Bn e 2022.

I-Diabetes Wearables Market kulindeleke ukuthi ifinyelele esilinganisweni se I-USD 36.25 Bn ngo-2032 ku-CAGR ye 6.3%, kusukela USD 20.92 Bn e 2021

imakethe yezokuphepha ye-Intanethi Yezinto Yezempilo yomhlaba (IoT). kulindeleke ukuthi ifinyelele esilinganisweni se I-USD 36.27 Bn ngo-2032 a I-CAGR of 36%, kusukela I-USD 1.68 Bn e 2022.

imakethe yamadivayisi we-pancreas wokwenziwa emhlabeni jikelele bekufanelekile USD 208.1 wezigidi ngo-2021. Kulindeleke ukuthi ikhule ku-CAGR ye 19.1% phakathi kwe-2023 kuya ku-2032.

imakethe yokunakekelwa kwempilo yasekhaya emhlabeni jikelele bekufanelekile I-USD 311.54 billion ngo-2021. Lesi sibalo sizokhula ngo-a I-CAGR ye-8.4% phakathi kuka-2023-2032

Mayelana ne-Market.us

I-Market.US (Inikwe amandla yi-Prudour Private Limited) igxile ocwaningweni olujulile lwemakethe nokuhlaziya futhi ibilokhu ifakazela ukuqina kwayo njengenkampani yokubonisana neyenziwe ngendlela oyifisayo yocwaningo lwemakethe, ngaphandle kokuba ngumbiko ofunwa kakhulu wocwaningo lwemakethe ohlinzeka ngokuqinile.

Imininingwane Yokuxhumana:

Ithimba Lokuthuthukiswa Kwebhizinisi Lomhlaba Wonke - Market.us

Ikheli: 420 Lexington Avenue, Suite 300 New York City, NY 10170, United States

Ucingo: +1 718 618 4351 (International), Ucingo: +91 78878 22626 (Asia)

Email: [i-imeyili ivikelwe]